Bausch Health Companies (BHC) Short term Debt (2009 - 2026)

Bausch Health Companies has disclosed Short term Debt across 17 years of filings, most recently posting $866.0 million for Q2 2026.

• In Q2 2026, Short term Debt fell 1.48% year-over-year to $866.0 million; the TTM figure through Jun 2026 stood at $866.0 million (down 1.48% YoY), while the FY2025 annual figure was $225.0 million, down 91.59% from the prior year.
• Short term Debt came in at $866.0 million for Q2 2026 at Bausch Health Companies, down from $889.0 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $2.7 billion in Q4 2024 to a low of $150.0 million in Q2 2022.
• Average Short term Debt over 5 years is $629.8 million, with a median of $452.0 million recorded in 2024.
• Year-over-year, Short term Debt jumped 494.22% in 2024 and slumped 91.59% in 2025.
• Over 5 years, Short term Debt stood at $432.0 million in 2022, then gained by 4.17% to $450.0 million in 2023, then jumped by 494.22% to $2.7 billion in 2024, then tumbled by 91.59% to $225.0 million in 2025, then jumped by 284.89% to $866.0 million in 2026.
• Per Business Quant data, the three most recent Short term Debt figures were $866.0 million in Q2 2026, $889.0 million in Q1 2026, and $225.0 million in Q4 2025.